Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sugammadex dosing by ideal vs actual body weight in underweight adults under general anesthesia
jRCT1031230452Completed
- Sponsor
- Nihon University Itabashi Hospital
- Start
- Nov 2023
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Randomised trial of Sugammadex in None (2 arms), sponsored by Nihon University Itabashi Hospital. Primary endpoint: Time to TOFR 90%. Started Nov 2023; status: completed.
02
Drugs
Sugammadex
Beyond the preview
Go deeper on jRCT1031230452.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1031230452.